UBS Group
AMSG

UBS Group’s Amsurg Corp AMSG Stock Holding History

UBS Group’s Portfolio AMSG Stock Details AMSG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-43,160
Closed -$2.89M – 8367
2016
Q3 		$2.89M Sell
43,160
-41,563
-49% -$2.9M ﹤0.01% 2509
2016
Q2 		$6.57M Buy
84,723
+43,725
+107% +$3.38M ﹤0.01% 1716
2016
Q1 		$3.06M Sell
40,998
-39,978
-49% -$2.82M ﹤0.01% 2302
2015
Q4 		$6.15M Buy
80,976
+31,321
+63% +$2.48M ﹤0.01% 1793
2015
Q3 		$3.86M Buy
49,655
+18,186
+58% +$1.4M ﹤0.01% 2145
2015
Q2 		$2.2M Buy
31,469
+14,857
+89% +$993K ﹤0.01% 2880
2015
Q1 		$1.02M Buy
16,612
+5,724
+53% +$330K ﹤0.01% 3558
2014
Q4 		$596K Buy
+10,888
New +$555K ﹤0.01% 4036

Other funds holding AMSG

AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BTS
BB&T Securities Richmond, Virginia $10.9B AUM 5.31% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $5.64B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

UBS Group's AMSG Position: Q4 2016 in Review

UBS Group sold out of Amsurg Corp (AMSG) in Q4 2016, closing a stake of 43,160 shares — an estimated $2.89M sold.

UBS Group first reported a position in AMSG in Q4 2014 and held it in 8 quarters. The position peaked at $6.57M in Q2 2016. 7 funds tracked by Wall St. Rank hold AMSG as of Q4 2016.

  • UBS Group reported no remaining Amsurg Corp position as of Q4 2016 after selling out during the quarter.
  • UBS Group sold 43,160 Amsurg Corp shares in Q4 2016, an estimated $2.89M.
  • UBS Group first reported a position in Amsurg Corp in Q4 2014 and held it in 8 quarters.
  • UBS Group's Amsurg Corp position peaked at $6.57M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Amsurg Corp as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.